NDC product
DERMFREE Triple Antibiotic
NDC 85248-117 · Jiangxi Yudexi Pharmaceutical Co., LTD
Key facts
| Product NDC | 85248-117 |
|---|---|
| Proprietary name | DERMFREE Triple Antibiotic |
| Nonproprietary name | Triple Antibiotic |
| Substances | NEOMYCIN SULFATE, POLYMYXIN B, BACITRACIN ZINC |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Labeler | Jiangxi Yudexi Pharmaceutical Co., LTD |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M004 |
| Pharmacologic classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| Marketing start | Feb 9, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: